cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lantheus Holdings
9 own
8 watching
Current Price
$60.02
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,129.92M
52-Week High
52-Week High
87.47
52-Week Low
52-Week Low
26.35
Average Volume
Average Volume
0.98M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
3377.0725
iconMarket Capitalization4,129.92M
icon52-Week High87.47
icon52-Week Low26.35
iconAverage Volume0.98M
iconDividend Yield--
iconP/E Ratio3377.0725
What does the Lantheus Holdings do?
Sells medical imaging agents used in the diagnosis of cardiovascular diseases.
Read More
How much money does Lantheus Holdings make?
News & Events about Lantheus Holdings.
Globe Newswire
27days ago
Enrollment for the randomization phase of SPLASH completed prior to EOY 2022, meeting previous guidanceINDIANAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the Company or POINT), a company accelerating the discovery, development, and global access to life-...
Globe Newswire
1month ago
NORTH BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.(the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, ...
Globe Newswire
1month ago
INDIANAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance...
Globe Newswire
1month ago
NORTH BILLERICA, Mass., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today ...
Globe Newswire
1month ago
NORTH BILLERICA, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, ...
Frequently Asked Questions
Frequently Asked Questions
What is Lantheus Holdings share price today?
plus_minus_icon
Can Indians buy Lantheus Holdings shares?
plus_minus_icon
How can I buy Lantheus Holdings shares from India?
plus_minus_icon
Can Fractional shares of Lantheus Holdings be purchased?
plus_minus_icon
What are the documents required to start investing in Lantheus Holdings stocks?
plus_minus_icon
What is today’s traded volume of Lantheus Holdings?
plus_minus_icon
What is today’s market capitalisation of Lantheus Holdings?
plus_minus_icon
What is the 52-Week High and Low Range of Lantheus Holdings?
plus_minus_icon
What percentage is Lantheus Holdings down from its 52-Week High?
plus_minus_icon
What percentage is Lantheus Holdings up from its 52-Week Low?
plus_minus_icon
Current Price
$60.02
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00